Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study
Authors:
- Noriko NishikawaNNNoriko Nishikawa
- Taku HatanoTHTaku Hatano
- Kenya NishiokaKNKenya Nishioka
- Shin-Ichi UenoSUShin-Ichi Ueno
- Shinji SaikiSSShinji Saiki
- Ryota NakamuraRNRyota Nakamura
- Asako YoritakaAYAsako Yoritaka
- Takashi OgawaTOTakashi Ogawa
- Yasushi ShimoYSYasushi Shimo
- Wataru SakoWSWataru Sako
- Hideki ShimuraHSHideki Shimura
- Yoshiaki FurukawaYFYoshiaki Furukawa
Open Access
- 17 May 2024
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 461, 123051
Abstract
No abstract availableKeywords
Funding Information
- Eisai Co Ltd
- Eisai Canada
This publication has 30 references indexed in Scilit:
- Analgesic effect of safinamide mesylate in a rat model of neuropathic painBehavioural Brain Research, 2023
- The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson’s Disease with Motor FluctuationsCNS Drugs, 2022
- Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III studyJournal of Neural Transmission, 2022
- Characteristics of wearing-off and motor symptoms improved by safinamide adjunct therapy in patients with Parkinson's disease: A post hoc analysis of a Japanese phase 2/3 studyJournal of the Neurological Sciences, 2022
- Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa TherapyJAMA Neurology, 2021
- Effects of safinamide adjunct therapy on pain in patients with Parkinson's disease: Post hoc analysis of a Japanese phase 2/3 studyJournal of the Neurological Sciences, 2021
- Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label studyJournal of the Neurological Sciences, 2020
- Effects of safinamide on pain in Parkinson’s disease with motor fluctuations: an exploratory studyJournal of Neural Transmission, 2020
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor FluctuationsJAMA Neurology, 2017
- Minimal clinically important difference on the Motor Examination part of MDS-UPDRSParkinsonism & Related Disorders, 2015